Skip to content
Home/Companies/TMT/Kinaset Therapeutics
KT

Kinaset Therapeutics

TMT·US·Active

Kinaset Therapeutics is a TMT company, headquartered in United States.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Kinaset Therapeutics?

Kinaset Therapeutics is currently owned by Gimv.

Hand-verified · updated 2026-04-21

Gimv
Investor
Gimv
Fund attribution unclassified.

Key facts

HQUnited States
SectorTMT

More from Gimv Portfolio

Other portfolio companies in the same fund.

Ablynx
Exited 2013
TMTBelgium
Acceo
Active
TMTBelgium
Acertys Group
Exited 2015
TMTBelgium
to
ActoGeniX
Exited 2015
TMTBelgium
to
AgroBiothers
Active
TMTBelgium
Almaviva
Exited 2017
TMTBelgium
to

More PE-backed in TMT

Comparable tmt deals from other GPs.

1500h
Active
QUANTONATION VENTURESFrance
24ORE
Active
FemuQui VenturesFrance
2Checkout (Avangate)
Exited
Francisco PartnersUS
3878 Best
Active
QUANTONATION VENTURES
3Bee
Active
AgFunderUS
3ma group
Active
Isatis CapitalFrance
Data refreshed weekly · Sourced from public filings